I think ASH topline results are coming anyday. This was in October 2018:
"Dr. Arun Sanyal is also the lead Principal Investigator of our alcoholic steatohepatitis (“ASH”) clinical study at Virginia Commonwealth University, which study is also funded by the NIH. We have recruited a total of 56 patients which have been randomized into the study. The study is now closed to recruitment and top-line results are expected to be reported in 2019."
Immuron has mentioned in a number of filings, including this same filing in other spots, that ASH results will be out 1st Q 2019.
Pediatric NASH Study, page-4
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
10.3¢ |
Change
0.007(6.77%) |
Mkt cap ! $23.36M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $17.48K | 171.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 319492 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 247866 | 7 |
View Market Depth
| Last trade - 10.46am 16/08/2024 (20 minute delay) ? |
| IMC (ASX) Chart |